Develops a molecular insights and diagnostic platform for blood cancers, using whole-genome sequencing of circulating tumor cells from blood or bone marrow samples and single-cell immune profiling to support therapy selection, risk stratification, measurable residual disease assessment, and longitudinal monitoring
Develops a molecular insights and diagnostic platform for blood cancers, using whole-genome sequencing of circulating tumor cells from blood or bone marrow samples and single-cell immune profiling to support therapy selection, risk stratification, measurable residual disease assessment, and longitudinal monitoring. Its platform also supports biopharma biomarker discovery, patient stratification, companion diagnostic development, and clinical trials.